IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $425,023 | +11.9% | 9,370 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $379,856 | +7.2% | 9,258 | -6.6% | 0.00% | 0.0% |
| Q1 2023 | $354,219 | -32.5% | 9,911 | -28.7% | 0.00% | -50.0% |
| Q4 2022 | $525,116 | -16.4% | 13,903 | -2.1% | 0.00% | 0.0% |
| Q3 2022 | $628,000 | +26.9% | 14,198 | +6.2% | 0.00% | 0.0% |
| Q2 2022 | $495,000 | -25.3% | 13,367 | -25.3% | 0.00% | +100.0% |
| Q1 2022 | $663,000 | -7.0% | 17,901 | -23.6% | 0.00% | 0.0% |
| Q4 2021 | $713,000 | -36.6% | 23,432 | -30.1% | 0.00% | -66.7% |
| Q3 2021 | $1,124,000 | -7.4% | 33,499 | +10.1% | 0.00% | -25.0% |
| Q2 2021 | $1,214,000 | +22.0% | 30,423 | +37.4% | 0.00% | +33.3% |
| Q1 2021 | $995,000 | -26.9% | 22,135 | -8.1% | 0.00% | -40.0% |
| Q4 2020 | $1,362,000 | +15.1% | 24,090 | -3.4% | 0.01% | 0.0% |
| Q3 2020 | $1,183,000 | -17.4% | 24,929 | +2.6% | 0.01% | -37.5% |
| Q2 2020 | $1,433,000 | +39.7% | 24,309 | +12.0% | 0.01% | +14.3% |
| Q1 2020 | $1,026,000 | -49.3% | 21,707 | -35.2% | 0.01% | -22.2% |
| Q4 2019 | $2,022,000 | -17.8% | 33,476 | -18.4% | 0.01% | -35.7% |
| Q3 2019 | $2,459,000 | -13.8% | 41,040 | -7.5% | 0.01% | -17.6% |
| Q2 2019 | $2,852,000 | -32.8% | 44,381 | -15.1% | 0.02% | -32.0% |
| Q1 2019 | $4,244,000 | +54.9% | 52,288 | +3.2% | 0.02% | +31.6% |
| Q4 2018 | $2,739,000 | -12.7% | 50,675 | -16.7% | 0.02% | -9.5% |
| Q3 2018 | $3,138,000 | +35.1% | 60,829 | +9.1% | 0.02% | +31.2% |
| Q2 2018 | $2,323,000 | -13.9% | 55,743 | -8.9% | 0.02% | -11.1% |
| Q1 2018 | $2,697,000 | -24.0% | 61,179 | -13.3% | 0.02% | -28.0% |
| Q4 2017 | $3,551,000 | -4.1% | 70,598 | -3.3% | 0.02% | -26.5% |
| Q3 2017 | $3,701,000 | +9.9% | 73,005 | +10.2% | 0.03% | 0.0% |
| Q2 2017 | $3,369,000 | +24.6% | 66,230 | -1.5% | 0.03% | +21.4% |
| Q1 2017 | $2,704,000 | -30.9% | 67,269 | -17.8% | 0.03% | -34.9% |
| Q4 2016 | $3,913,000 | +34.2% | 81,808 | +2.8% | 0.04% | +4.9% |
| Q3 2016 | $2,916,000 | +33.3% | 79,587 | -15.3% | 0.04% | +46.4% |
| Q2 2016 | $2,187,000 | -41.3% | 93,913 | +2.2% | 0.03% | -45.1% |
| Q1 2016 | $3,723,000 | -40.5% | 91,916 | -9.1% | 0.05% | -32.9% |
| Q4 2015 | $6,261,000 | – | 101,095 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |